Does RUXOLITINIB Cause Haemoglobin abnormal? 500 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 500 reports of Haemoglobin abnormal have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.7% of all adverse event reports for RUXOLITINIB.
500
Reports of Haemoglobin abnormal with RUXOLITINIB
0.7%
of all RUXOLITINIB reports
21
Deaths
87
Hospitalizations
How Dangerous Is Haemoglobin abnormal From RUXOLITINIB?
Of the 500 reports, 21 (4.2%) resulted in death, 87 (17.4%) required hospitalization, and 11 (2.2%) were considered life-threatening.
Is Haemoglobin abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 500 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Haemoglobin abnormal?
ECULIZUMAB (466)
VENETOCLAX (248)
DARBEPOETIN ALFA (213)
ADALIMUMAB (207)
LENALIDOMIDE (172)
RITUXIMAB (157)
ERYTHROPOIETIN (154)
IBRUTINIB (148)
DEXAMETHASONE (147)
CYCLOPHOSPHAMIDE (122)
Which RUXOLITINIB Alternatives Have Lower Haemoglobin abnormal Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE